Abstract:Manganese dioxide nanoparticles (MnO 2 -NPs) have a wide range of applications in biomedicine. Given this widespread usage, it is worth noting that MnO 2 -NPs are definitely toxic, especially to the brain. However, the damage caused by MnO 2 -NPs to the choroid plexus (CP) and to the brain after crossing CP epithelial cells has not been elucidated. Therefore, this study aims to investigate these effects and elucidate potential underlying mechanisms through transcriptomics analysis. To achieve this objective, eighteen SD rats were randomly divided into three groups: the control group (control), low-dose exposure group (low-dose) and high-dose exposure group (high-dose). Animals in the two treated groups were administered with two concentrations of MnO 2 -NPs (200 mg kg −1 BW and 400 mg kg −1 BW) using a noninvasive intratracheal injection method once a week for three months. Finally, the neural behavior of all the animals was tested using a hot plate tester, open-field test and Y-type electric maze. The morphological characteristics of the CP and hippocampus were observed by H&E stain, and the transcriptome of CP tissues was analysed by transcriptome sequencing. The representative differentially expressed genes were quantified by qRT-PCR. We found that treatment with MnO 2 -NPs could induce learning capacity and memory faculty decline and destroy the structure of hippocampal and CP cells in rats. High doses of MnO 2 -NPs had a more obvious destructive capacity. For transcriptomic analysis, we found that there were significant differences in the numbers and types of differential genes in CP between the low- and high-dose groups compared to the control. Through GO terms and KEGG analysis, high-dose MnO 2 -NPs significantly affected the expression of transporters, ion channel proteins, and ribosomal proteins. There were 17 common differentially expressed genes. Most of them were transporter and binding genes on the cell membrane, and some of them had kinase activity. Three genes, Brinp, Synpr and Crmp1, were selected for qRT-PCR to confirm their expression differences among the three groups. In conclusion, high-dose MnO 2 -NPs exposure induced abnormal neurobehaviour, impaired memory function, destroyed the structure of the CP and changed its transcriptome in rats. The most significant DEGs in the CP were within the transport system.

NMR-based Metabonomic Analysis of MnO-embedded Iron Oxide Nanoparticles As Potential Dual-Modal Contrast Agents

Studies on the acute biochemical effects of Nd(NO 3) 3 by nuclear magnetic resonance-based metabonomics

Metabonomic Studies on Intact Livers and Liver Extracts from Rats Treated with Neodymium Nitrate

NMR spectroscopic-based metabonomic investigation on the acute biochemical effects induced by Ce(NO3)3 in rats.

Effects Of Long-Term Exposure To Zinc Oxide Nanoparticles On Development, Zinc Metabolism And Biodistribution Of Minerals (Zn, Fe, Cu, Mn) In Mice

Effects of iron oxide nanoparticle labeling on human endothelial cells.

Metabolic Conversion and Removal of Manganese Ferrite Nanoparticles in RAW264.7 Cells and Induced Alteration of Metal Transporter Gene Expression

Characterization and Cellular Toxicity Studies of Commercial Manganese Oxide Nanoparticles

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics

Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents

NMR-based Metabonomic Analyses of the Effects of Ultrasmall Superparamagnetic Particles of Iron Oxide (USPIO) on Macrophage Metabolism

Transcriptomics-based investigation of manganese dioxide nanoparticle toxicity in rats' choroid plexus

Characterization and in Vitro Cellular Uptake of PEG Coated Iron Oxide Nanoparticles As MRI Contrast Agent.

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Effects of food-grade iron(III) oxide nanoparticles on cecal digesta- and mucosa-associated microbiota and short-chain fatty acids in rats

Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review

Structure-property Relationships in Manganese Oxide - Mesoporous Silica Nanoparticles Used for T1-weighted MRI and Simultaneous Anti-Cancer Drug Delivery

Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in male mice

MnO 2 nanoparticles trigger hepatic lipotoxicity and mitophagy via mtROS-dependent Hsf1 Ser326 phosphorylation

Synthesis and characterization of PEG-coated Zn$_{0.3}$Mn$_x$Fe$_{2.7-x}$O$_4$ nanoparticles as the dual T1/T2-weighted MRI contrast agent